Red-State Universities Will Get Hit by Trump's Cuts, Too
A few weeks ago, on social media, President Trump wrote, 'I am considering taking Three Billion Dollars of Grant Money away from a very antisemitic Harvard, and giving it to TRADE SCHOOLS all across our land. What a great investment that would be for the USA.'
The message was, presumably, that by going to war with Harvard, he's getting a twofer: sticking it to 'woke' blue-state elites while also making blue-collar workers in red states a priority. He's not wrong that we should invest more in vocational education and do more to improve the economic conditions for working-class Americans.
But his joust with Harvard — his moves, in particular, to freeze more than $2 billion in federal research funding and cancel federal contracts with the university — is just the most visible part of a wider assault on institutions of higher learning. Last month, Nature reported that the administration has proposed cutting over $20 billion from the budget for the National Institutes of Health; The Times reported that grants funded by the National Science Foundation were down more than 50 percent compared with the average from 2015 to 2024.
Rather than striking a blow for red-state America, these cuts would actually take a heavy toll on many of the communities in states that went for Mr. Trump in the last election — whose research universities serve as crucial anchors for industry and innovation.
If Mr. Trump wants to make all of America great again, he shouldn't cut funding for scientific research. He should increase it.
According to a recent report, over the past decade, N.I.H. research funding, which in large part is distributed to universities in the form of grants, has helped generate $787 billion for the American economy and an average of more than 370,000 jobs each year. Every dollar of N.I.H.-funded research generates a total of $2.56 in economic activity.
Want all of The Times? Subscribe.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
10 minutes ago
- Washington Post
D.C. attorney general alleges violence intervention nonprofit misused funds
The District's attorney general has alleged that a nonprofit group hired by the city misappropriated funds that were supposed to go toward preventing gun violence in the Congress Heights neighborhood. In a lawsuit filed this week by D.C. Attorney General Brian L. Schwalb, the city is seeking to recoup more than $250,000 in government funds that went to Women in H.E.E.L.S. (Healing, Elevation, Empowerment, Love, Support) Inc. The group signed an agreement with the attorney general's office in March 2022 to operate one of four new violence-reduction program sites as part of the office's Cure the Streets program, according to the suit.
CNN
10 minutes ago
- CNN
Hundreds of Americans have fled Iran and others face difficulties leaving as Trump weighs US military action
Hundreds of Americans have fled Iran as the conflict with Israel has escalated, an internal State Department report said. The detail in the Friday situation report underscores that US citizens in Iran are at risk as President Donald Trump weighs US military action. The exact number of Americans in Iran is not known, and the State Department does not require US citizens to register their presence abroad. Unlike in Israel, where the US is working to establish transportation options out of the country for the estimated hundreds of thousands of Americans there, no such options are available for US citizens in Iran. The US does not have a diplomatic presence there. 'We do not anticipate offering direct US government assisted departure from Iran,' State Department spokesperson Tammy Bruce noted at a press briefing Friday. The situation report described some Americans facing difficulties leaving Iran. 'Security alerts also note Americans seeking to depart should be prepared to encounter checkpoints and questioning from authorities,' it states. 'Numerous US citizens have described delays and harassment along their exit route.' It also notes that two Americans were reportedly detained while attempting to depart the country. One source trying to get a US citizen family member out of Iran expressed frustration at the State Department earlier this week, saying the agency seemed to defer everything to seemingly overwhelmed US embassies. This person wanted to see the department apply more pressure to Iran's neighboring countries to approve Americans' entrance. They also suggested dispatching embassy officials closer to the Iranian border to help. More than 25,000 people have sought information from the State Department about the 'situation in Israel, the West Bank and Iran,' Bruce said Friday. Bruce said that the people were seeking 'general information,' and some of them might be inquiring about departure. The department has launched a 'crisis intake form' for Americans in Israel and Iran wanting to know how to get out of those countries as the conflict continues. 'Americans seeking departure should take advantage of existing means to leave,' Bruce noted at the press briefing. Meanwhile, US Ambassador to Israel Mike Huckabee said Thursday that the US is 'working to get military, commercial, charter flights & cruise ships' for evacuation from Israel. Trump on Thursday opened a two-week negotiating window before deciding whether to strike Iran, setting off an urgent effort to restart talks that had been deadlocked when Israel began its bombing campaign last week.
Yahoo
14 minutes ago
- Yahoo
Scholar Rock (SRRK) Jumps 16.6% After Successful Weight Loss Drug Trial
We recently published a list of These 10 Stocks Boast Double-Digit Gains Amid Boring Market. Scholar Rock Holding Corporation (NASDAQ:SRRK) is one of the best-performing stocks on Thursday. Scholar Rock jumped by 16.6 percent on Wednesday to close at $36.32 apiece as investor sentiment was bolstered by the positive results from the second phase of its weight loss drug trial. In a statement, Scholar Rock Holding Corporation (NASDAQ:SRRK) said the trial, which aims to assess its drug candidate apitegromab's combination with tirzepatide, was generally well tolerated, leading to higher quality weight loss as compared with taking tirzepatide alone. According to Scholar Rock Holding Corporation (NASDAQ:SRRK), apitegromab therapy in combination with tirzepatide resulted in the preservation of 4.2 pounds of lean mass compared with tirzepatide alone. 'While this is an exciting development for our platform, we remain focused on preparing for the launch of apitegromab, and following its potential approval in SMA, we look forward to studying it in a range of neuromuscular diseases with high unmet need,' said Scholar Rock Holding Corporation (NASDAQ:SRRK) President and CEO Akshay Vaishnaw, adding that he was looking forward to exploring its potential in various rare, severe debilitating neuromuscular disorders. A scientist holding a flask of liquid in a laboratory, highlighting the research and discoveries of new treatments. 'We remain on track to file an IND application for SRK-439 in the second half of this year to support the first in human study,' he said. While we acknowledge the potential of SRRK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
